Liquidia Corp (LQDA) Stock Price, Quote & News

Company Profile

Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for rare cardiopulmonary diseases in the United States. The company's lead product candidates include YUTREPIA, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease (PH-ILD). It also provides Remodulin, a treprostinil injection administered through continuous intr...

Industry: Drug Manufacturers - Specialty & Generic

Sector: Healthcare

Phone: 919 328 4400

Fax: 919 328 4402

Website: www.liquidia.com

Address:

419 Davis Drive, Suite 100, Morrisville, United States

QuantInsider Apr. 15 at 2:35 AM

$LQDA just saw a big move with near-term OTM puts for this Friday Seeing about 4,500 contracts at 30 and 33.5 strikes, way above open interest Feels like a caution flag for short-term longs rather than just noise No fresh news and only small price moves, so this looks like early protective positioning Might be smart to wait for more bearish flow or selling before making any big trades Keep in mind, implied vol on these weeklies is sky-high around 130 to 170 percent Anyone jumping in now is paying hefty premiums with just three days to expiry Could face some serious decay if $LQDA doesn’t drop fast

0 · Reply

BullRun4 Apr. 15 at 12:58 AM

$LQDA Bullish

0 · Reply

KeelinTime Apr. 14 at 10:16 PM

$LQDA

0 · Reply

Hamboning0 Apr. 14 at 3:04 PM

$LQDA It’s so typical of LQDA to trade down into red territory while the entire market is going up massively.

1 · Reply

stevemano Apr. 13 at 3:30 PM

$LQDA

0 · Reply

StockMacroView Apr. 13 at 9:41 AM

$LQDA | Timeline Alert: Monday marks 17 days since Judge Andrews’ last ruling. Since Jan 2025, gaps exceeding two weeks have been historical outliers. We are currently testing the limits of the typical judicial cadence. The silence suggests a pivotal decision is imminent. Market tension is peaking as we wait for the gavel to drop on this consolidation phase. It’s time. 👉Click to view @StockMacroView for timely updates amid the volatility.

0 · Reply

BioTechHealthX Apr. 12 at 5:56 AM

$CRDL $INO $LQDA $OCGN $TERN These top 10 microcap biotech stocks are gaining momentum with strong pipelines and upcoming catalysts. Discover the high-growth biotech companies that could deliver explosive returns in today’s market. https://biotechhealthx.com/biotech-news/top-10-microcap-biotech-stocks-that-could-multiply-your-money-fast/

1 · Reply

BioTechHealthX Apr. 12 at 2:52 AM

$EYPT $LQDA $OCGN $URGN $VRDN The biotech sector is heating up again. These top 5 best microcap biotech stocks are gaining traction with strong pipelines, upcoming trial results, and serious upside potential investors shouldn’t ignore. https://biotechhealthx.com/biotech-news/top-5-best-microcap-biotech-stocks-that-could-explode-10x-in-2026/

0 · Reply

KeelinTime Apr. 11 at 6:29 PM

$LQDA

0 · Reply

MinimalistKLine Apr. 11 at 7:20 AM

$LQDA Back in January, we saw an early Q4 revenue PR on the first Friday of the quarter. The bid over the last few days was clearly betting on a repeat performance for Q1 today, but since that didn't materialize, we're seeing the "expectation trade" unwind. That said, the window isn't closed—management still has the opportunity to drop some preliminary figures at next week's conferences. Ultimately, the timing is secondary to the results, which are expected to be fantastic whenever they land. Ignore the short-term noise and stay the course.

0 · Reply